RESTORE-1 (Completed)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of Flecainide
Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation
to Sinus Rhythm
- Medicine
- FlecIH-103
- Population
- Arrhythmia
- Phase
- III
- Starting year
- 2021